ASML Holding
ASML
Advanced Micro Devices
AMD
Taiwan Semiconductor
TSM
Alibaba
BABA
Cisco
CSCO
US Stock MarketDetailed Quotes
PRQR ProQR Therapeutics
- 2.7600
- +0.0800+2.99%
Trading Dec 27 12:20 ET
292.30MMarket Cap-8.82P/E (TTM)
2.7900High2.6600Low184.90KVolume2.6600Open2.6800Pre Close507.13KTurnover0.23%Turnover RatioLossP/E (Static)105.91MShares4.620052wk High11.22P/B226.54MFloat Cap1.610052wk Low--Dividend TTM82.08MShs Float27.6000Historical High--Div YieldTTM4.85%Amplitude0.5300Historical Low2.7420Avg Price1Lot Size
ProQR Therapeutics Key Stats
EPS
According to the latest financial report of ProQR Therapeutics, the latest earnings per share (TTM) for the company is -0.10. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: EUR
Quarterly
Loading...
FCF
Interested in knowing about ProQR Therapeutics's free cash flow? The latest report shows it as -5.94M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: EUR
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ProQR Therapeutics shows that the company's current ratio is 2.33, indicating healthy liquidity.
Currency: EUR
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ProQR Therapeutics, the quick ratio is 2.29, indicating that the company can meet its short-term debt obligations.
Currency: EUR
Quarterly
Loading...
ROE
Want to learn more about the financial health of ProQR Therapeutics? The latest ROE figure is -28.04%, indicating that the company has stable profitability.
Currency: EUR
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ProQR Therapeutics, the total asset return on investment (ROA) is -7.21%.
Currency: EUR
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ProQR Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: EUR
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ProQR Therapeutics, the net profit margin is -210.98%, which is a good sign for its profitability.
Currency: EUR
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.